Generate Biomedicines revenue was $31.89M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GENB annual revenue was $31.9M, with 55.9% growth year-over-year.
GENB past revenue growth
How has GENB's revenue growth performed historically?
Generate Biomedicines (NASDAQ: GENB) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Generate Biomedicines's revenue was N/A.
What was Generate Biomedicines's revenue in 2025?
Generate Biomedicines's annual revenue for the twelve months ending Dec 31, 2025 was $31.89 million, a 55.89% increase year over year.
How much does Generate Biomedicines make in a day?
Based on Generate Biomedicines annual revenue for the past one years, GENB makes an average of $87,378.08 per day.
What was Generate Biomedicines's annual revenue growth in the past year?
As of Q1 2026, Generate Biomedicines's revenue has grown 55.89% year over year. This is 370.08 percentage points lower than the US Biotechnology industry revenue growth rate of 425.96%. Generate Biomedicines's revenue in the past year totaled $31.89 million.
How much does Generate Biomedicines make in a year?
Generate Biomedicines's revenue by year for the past one years is:
Generate Biomedicines's revenue for the twelve months ending Dec 31, 2025 was $31.89 million, a 55.89% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.